BAM
VXRT

Belpointe Asset Management’s Vaxart VXRT Stock Holding History

Belpointe Asset Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,463
Closed -$1.86K – 3340
2023
Q1 		$1.86K Sell
2,463
-3
-0.1% -$3 ﹤0.01% 3321
2022
Q4 		$2.37K Buy
+2,466
New +$3.48K ﹤0.01% 3206

Other funds holding VXRT

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Belpointe Asset Management's VXRT Position: Q2 2023 in Review

Belpointe Asset Management sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 2,463 shares — an estimated $1.86K sold.

Belpointe Asset Management first reported a position in VXRT in Q4 2022 and held it in 2 quarters. The position peaked at $2.37K in Q4 2022. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Belpointe Asset Management reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 2,463 Vaxart shares in Q2 2023, an estimated $1.86K.
  • Belpointe Asset Management first reported a position in Vaxart in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Vaxart position peaked at $2.37K in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.